| 查看: 327 | 回复: 0 | |||
[交流]
单一和多重过敏呼吸道变应性疾病儿童舌下特异性免疫治疗的疗效和安全性
|
|
Background: The efficacy of single-allergen-specific immunotherapy in polysensitized subjects is a matter of debate. This study aimed to investigate the efficacy of house dust mite (HDM) sublingual immunotherapy (SLIT) in monosensitized and polysensitized children. Methods: A total of 112 children, aged 4 to 13 years old, with HDM-induced respiratory allergic diseases were allocated to a monosensitized group (n = 56) or a polysensitized group (n = 56). Both groups were treated by standard pharmacotherapy and SLIT with Dermatophagoides farinae (American HDM) extracts for 52 weeks. Symptoms, medications, visual analogue scale (VAS), and presence of adverse events (AEs) were assessed once a month. Skinprick test (SPT) was done before and after treatment. After treatment, subjects in the polysensitized group who completed the study were further analyzed as subgroup 1 (n = 20) and subgroup (n = 15) according to the number of coexisting allergens. Results: Forty-one subjects in the monosensitized group and 35 subjects in the polysensitized group completed the study. The global clinical parameters had significantly improved aer treatment, with no significant difference between the monosensitized and polysensitized group throughout this period (all p > 0.05). The comparison among the monosensitized group, subgroup 1, and subgroup 2 indicated that there was no significant difference in symptoms scores and VAS at each scheduled follow-up visit. Therewas also no significant difference in total medications score (TMS) in the monosensitized group, subgroup 1, and subgroup 2 after week 24 (all p > 0.05). No severe systemic AEs were reported. Conclusion: No significant difference was observed in the clinical effects of HDM SLIT between polysensitized and monosensitized children with respiratory allergic diseases. |
» 猜你喜欢
CSC在职申请,我是劳务派遣员工,单位推荐意见表怎么填
已经有15人回复
信号通路中相互作用
已经有1人回复
医学免疫学论文润色/翻译怎么收费?
已经有232人回复
德国医学博士申请
已经有7人回复
公派读博,个人渠道还是合作项目?
已经有6人回复
R做相关图时报错,参数值意味着不同的行数: 91, 78
已经有0人回复
免疫荧光和FISH双染
已经有1人回复
基金祈福
已经有112人回复
291理学求调剂
已经有0人回复
超级细菌多重耐药性分子机制研究团队招收博士研究生
已经有0人回复













回复此楼